Combined chemo-radiotherapy in locally advanced nasopharyngeal carcinomas
Journal Title: World Journal of Clinical Oncology - Year 2013, Vol 4, Issue 2
Abstract
Data regarding patients with a histologically confirmed diagnosis of locally advanced NPC (T2bN0M0-T4bN3M0) and treated with chemotherapy and radiotherapy from March 2006 to March 2012 at the participating Institutions, were retrieved from reviewed charts. Patients underwent fiberoscopy with biopsy of the primitive tumor, and computed tomography (CT) scan of head, neck, chest and abdomen with and without contrast. A 18-fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) scan was performed in selected patients according to the physician’s judgment.
Authors and Affiliations
Francesco Perri, Giuseppina Della Vittoria Scarpati, Carlo Buonerba, Giuseppe Di Lorenzo, Francesco Longo, Paolo Muto, Concetta Schiavone, Fabio Sandomenico, Francesco Caponigro
Keywords
Related Articles
- EP ID EP679598
- DOI 10.5306/wjco.v4.i2.47
- Views 57
- Downloads 0
Statin a day keeps cancer at bay
In addition to cholesterol reduction, statins, currently the most commonly prescribed drug in the world, have been shown to have anti-neoplastic and immunomodulatory effects. Several observational studies and meta-analys...
Combined chemo-radiotherapy in locally advanced nasopharyngeal carcinomas
Data regarding patients with a histologically confirmed diagnosis of locally advanced NPC (T2bN0M0-T4bN3M0) and treated with chemotherapy and radiotherapy from March 2006 to March 2012 at the participating Institutions,...
Molecularly targeted therapies for advanced or metastatic non-small-cell lung carcinoma
Non-small-cell lung cancer (NSCLC) remains the leading cause of cancer-related death in both men and women in the United States. Platinum-based doublet chemotherapy has been a standard for patients with advanced stage di...
Non-AIDS-related Kaposi's sarcoma: A single-institution experience
Disease control rate is 93.7%.